Soft tissue sarcoma : Opening the door to advances in diagnosis and treatment
β Scribed by J. Sybil Biermann; Laurence H. Baker
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 30 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Standard therapy for pediatric nonrhabdomyosarcoma soft tissue sarcomas (pnrsts) consists of surgical resection with or without radiotherapy. the role of chemotherapy in the treatment of these tumors has not yet been defined. we investigated the efficacy and toxicity of an ifosfamide
## BACKGROUND. Successful chemotherapy for patients with soft tissue sarcoma (STS) has been limited by a lack of active drugs. The most effective single agents are doxorubicin, dacarbazine, and, more recently, ifosfamide. Previously the most widely used combination has been CYVADIC (cyclophosphami
## Background: Extremity soft tissue sarcoma (sts) metastasizes preferentially to the lungs via the hematogenous route. metastases in extrapulmonary sites such as bone, brain, and subcutaneous tissues are observed less frequently. to the authors' knowledge, limb sts primarily metastasizing to the r